Technical Analysis for ACRS - Aclaris Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Historical ACRS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Reversal New Lows Setup | Bearish Swing Setup | -0.24% | |
| Slingshot Bearish | Bearish Swing Setup | -0.24% | |
| Outside Day | Range Expansion | -0.24% | |
| Down 3 Days in a Row | Weakness | -0.24% | |
| Oversold Stochastic | Weakness | -0.24% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Down 2 % | 3 days ago |
| Fell Below Lower Bollinger Band | 3 days ago |
| 60 Minute Opening Range Breakdown | 3 days ago |
| Down 1% | 3 days ago |
| Up 3% | 3 days ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/01/2021
Aclaris Therapeutics, Inc., a clinical-stage specialty pharmaceutical company, focuses on identifying, developing, and commercializing topical drugs to address various unmet needs in dermatology. Its lead drug candidate is A-101, a hydrogen peroxide topical solution that has completed three Phase II clinical trials for the treatment of seborrheic keratosis (SK), a common non-malignant skin tumor. The company is also developing A-101 as a prescription treatment for common warts; and A-102, a proprietary topical gel dosage form of hydrogen peroxide for the treatment of SK and common warts. Aclaris Therapeutics, Inc. was founded in 2012 and is headquartered in Malvern, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Stage Specialty Pharmaceutical Hydrogen Peroxide Topical Medication Common Warts Keratosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Pharmaceutical Chemical Substances Hydrogen Dermatology Stage Specialty Pharmaceutical Hydrogen Peroxide Topical Medication Common Warts Keratosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 30.375 |
| 52 Week Low | 1.2 |
| Average Volume | 606,023 |
| 200-Day Moving Average | 11.80 |
| 50-Day Moving Average | 24.97 |
| 20-Day Moving Average | 24.36 |
| 10-Day Moving Average | 22.94 |
| Average True Range | 1.59 |
| ADX | 22.09 |
| +DI | 10.35 |
| -DI | 22.61 |
| Chandelier Exit (Long, 3 ATRs ) | 23.47 |
| Chandelier Exit (Short, 3 ATRs ) | 25.45 |
| Upper Bollinger Band | 27.97 |
| Lower Bollinger Band | 20.75 |
| Percent B (%b) | 0.06 |
| BandWidth | 29.67 |
| MACD Line | -1.06 |
| MACD Signal Line | -0.61 |
| MACD Histogram | -0.4503 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 23.22 | ||||
| Resistance 3 (R3) | 23.27 | 22.65 | 22.88 | ||
| Resistance 2 (R2) | 22.65 | 22.13 | 22.62 | 22.76 | |
| Resistance 1 (R1) | 21.92 | 21.82 | 21.61 | 21.87 | 22.65 |
| Pivot Point | 21.30 | 21.30 | 21.15 | 21.27 | 21.30 |
| Support 1 (S1) | 20.57 | 20.78 | 20.26 | 20.52 | 19.73 |
| Support 2 (S2) | 19.95 | 20.47 | 19.92 | 19.62 | |
| Support 3 (S3) | 19.22 | 19.95 | 19.50 | ||
| Support 4 (S4) | 19.17 |
